Ngo, C., Borcoman, E., Rapinat, A., Simaga, F., Mouterfi, N., Mariani, O., . . . Vincent-Salomon, A. (2019). 260P - PAM50 and CGH-array genomic characterization of HER2-equivocal breast cancers defined by the 2018 ASCO/CAP recommendations. Annals of Oncology, 30, v87. https://doi.org/10.1093/annonc/mdz240.084
Chicago Style (17th ed.) CitationNgo, C., et al. "260P - PAM50 and CGH-array Genomic Characterization of HER2-equivocal Breast Cancers Defined by the 2018 ASCO/CAP Recommendations." Annals of Oncology 30 (2019): v87. https://doi.org/10.1093/annonc/mdz240.084.
MLA (9th ed.) CitationNgo, C., et al. "260P - PAM50 and CGH-array Genomic Characterization of HER2-equivocal Breast Cancers Defined by the 2018 ASCO/CAP Recommendations." Annals of Oncology, vol. 30, 2019, p. v87, https://doi.org/10.1093/annonc/mdz240.084.